FOXD1 Expression Is Associated with Poor Prognosis in Non-small Cell Lung Cancer

被引：3
|
作者：
Nakayama, Sohei [1 ]
Soejima, Kenzo [1 ]
Yasuda, Hiroyuki [1 ]
Yoda, Satoshi [1 ]
Satomi, Ryosuke [1 ]
Ikemura, Shinnosuke [1 ]
Terai, Hideki [1 ]
Sato, Takashi [1 ]
Yamaguchi, Norihiro [2 ]
Hamamoto, Junko [1 ]
Arai, Daisuke [1 ]
Ishioka, Kota [1 ]
Ohgino, Keiko [1 ]
Naoki, Katsuhiko [1 ,3 ]
Betsuyaku, Tomoko [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Med, Div Pulm Med, Tokyo 1608582, Japan
[2] Beth Israel Deaconess Med Ctr, Dept Internal Med, New York, NY USA
[3] Keio Univ Hosp, Keio Canc Ctr, Tokyo, Japan
来源：
ANTICANCER RESEARCH | 2015年 / 35卷 / 01期
关键词：
FOXD1; non-small cell lung cancer; microarray; pathway signature; PTEN; GENE-EXPRESSION; PTEN LOSS; SIGNATURES; AKT; METASTASIS; SUPPRESSOR; ERLOTINIB; PROTEINS; SURVIVAL; FOXA2;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Aim: Clinical microarray datasets were analyzed to search for new therapeutic targets and prognostic markers of non-small cell lung cancer (NSCLC). Materials and Methods: Microarray datasets from 90 lung cancer specimens, were analyzed with focus on the FOXD1 gene. Levels of FOXDI mRNA were assessed in lung cancer cell lines and these levels were correlated with survival. Results: FOXD1-knockdown led to suppression of cell proliferation. Moreover, patients with high FOXDI expression survived for a significantly shorter time than those with low FOXDI expression. Conclusion: The expression status of FOXD1 is a novel prognostic factor and may lead to new treatment strategies for NSCLC.
引用
收藏
页码：261 / 268
页数：8
相关论文
共 50 条
  • [21] High Expression of PHGDH Predicts Poor Prognosis in Non-Small Cell Lung Cancer
    Zhu, Jinhong
    Ma, Jianqun
    Wang, Xudong
    Ma, Tianjiao
    Zhang, Shu
    Wang, Wei
    Zhou, Xiaoyu
    Shi, Jiahai
    TRANSLATIONAL ONCOLOGY, 2016, 9 (06): : 592 - 599
  • [22] High expression of MYEOV reflects poor prognosis in non-small cell lung cancer
    Zhang, Rui
    Ma, Aiqing
    GENE, 2021, 770
  • [23] Loss of Bad expression confers poor prognosis in non-small cell lung cancer
    Huang, Yi
    Liu, Dan
    Chen, Bojiang
    Zeng, Jing
    Wang, Lei
    Zhang, Shangfu
    Mo, Xianming
    Li, Weimin
    MEDICAL ONCOLOGY, 2012, 29 (03) : 1648 - 1655
  • [24] Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer
    Xu, Chun-Hua
    Sheng, Zhi-Hong
    Hu, Hui-Di
    Hao, Ke-Ke
    Wang, Qing-Bo
    Yu, Li-Ke
    TUMOR BIOLOGY, 2014, 35 (09) : 8673 - 8678
  • [25] Low expression of FZD1 correlates with poor prognosis in non-small cell lung cancer
    Su, Wenmei
    Ye, Haiyin
    Wu, Fenping
    Mo, Yanli
    Li, Shujun
    Mai, Zongjiong
    Guo, Kangwen
    Li, Lixia
    Wang, Dong
    Yang, Zhixiong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (08): : 8335 - 8342
  • [26] LYAR promotes the proliferation of non-small cell lung cancer and is associated with poor prognosis
    Lu, Xiao-Ning
    Ju, Guan-Jun
    Wang, Yu-Xin
    Wang, Yong-Liang
    Wang, Kun
    Chen, Jian-Le
    Cai, Wei
    Zang, Qi-Wei
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2021, 59 (04) : 282 - 290
  • [27] Overexpression of Derlin-1 is Associated with Poor Prognosis in Patients with Non-small Cell Lung Cancer
    Mao, Minhua
    Zhang, Jinsong
    Jiang, Jueru
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2018, 48 (01): : 29 - 34
  • [28] SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non-small cell lung cancer
    Azuma, Yoko
    Yokobori, Takehiko
    Mogi, Akira
    Altan, Bolag
    Yajima, Toshiki
    Kosaka, Takayuki
    Onozato, Ryoichi
    Yamaki, Ei
    Asao, Takayuki
    Nishiyama, Masahiko
    Kuwano, Hiroyuki
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 112 (02) : 231 - 237
  • [29] Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis
    Dalloneau, Emilie
    Baroukh, Nadine
    Mavridis, Konstantinos
    Maillet, Agnes
    Gueugnon, Fabien
    Courty, Yves
    Petit, Agnes
    Kryza, Thomas
    Del Rio, Maguy
    Guyetant, Serge
    Castaneda, Diana Carolina Cadena
    Dhommee, Christine
    Arnoult, Christophe
    Scorilas, Andreas
    Gouilleux-Gruart, Valerie
    Heuze-Vourc'h, Nathalie
    ONCOTARGET, 2016, 7 (34): : 54415 - 54429
  • [30] Reduced expression of thrombospondin-1 correlates with a poor prognosis in patients with non-small cell lung cancer
    Yamaguchi, M
    Sugio, K
    Ondo, K
    Yano, T
    Sugimachi, K
    LUNG CANCER, 2002, 36 (02) : 143 - 150
12345